Unknown

Dataset Information

0

Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.


ABSTRACT: The effects of the drug delivery system on the PDT activity, localization, and tumor accumulation of the novel photosensitizer temocene (the porphycene analogue of temoporfin or m-tetrahydroxyphenyl chlorin) were investigated against the P815 tumor, both in vitro and in DBA/2 tumor bearing mice. Temocene was administered either free (dissolved in PEG(400)/EtOH mixture), or encapsulated in Cremophor EL micelles or in DPPC/DMPG liposomes, chosen as model delivery vehicles. The maximum cell accumulation and photodynamic activity in vitro was achieved with the free photosensitizer, while temocene in Cremophor micelles hardly entered the cells. Notwithstanding, the micellar formulation showed the best in vivo response when used in a vascular regimen (short drug light interval), whereas liposomes were found to be an efficient drug delivery system for a tumor cell targeting strategy (long drug-light interval). PEG/EtOH formulation was discarded for further in vivo experiments as it provoked lethal toxic effects caused by photosensitizer aggregation. These results demonstrate that drug delivery systems modulate the vascular and cellular outcomes of photodynamic treatments with temocene.

SUBMITTER: Garcia-Diaz M 

PROVIDER: S-EPMC3438332 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.

García-Díaz María M   Kawakubo Masayoshi M   Mroz Pawel P   Sagristà M Lluïsa ML   Mora Margarita M   Nonell Santi S   Hamblin Michael R MR  

Journal of controlled release : official journal of the Controlled Release Society 20120727 2


The effects of the drug delivery system on the PDT activity, localization, and tumor accumulation of the novel photosensitizer temocene (the porphycene analogue of temoporfin or m-tetrahydroxyphenyl chlorin) were investigated against the P815 tumor, both in vitro and in DBA/2 tumor bearing mice. Temocene was administered either free (dissolved in PEG(400)/EtOH mixture), or encapsulated in Cremophor EL micelles or in DPPC/DMPG liposomes, chosen as model delivery vehicles. The maximum cell accumul  ...[more]

Similar Datasets

| S-EPMC5396058 | biostudies-literature
| S-EPMC5714340 | biostudies-literature
| S-EPMC10970349 | biostudies-literature
| S-EPMC7072360 | biostudies-literature
| S-EPMC10055832 | biostudies-literature
| S-EPMC2362044 | biostudies-literature
| S-EPMC3172889 | biostudies-other
| S-EPMC3956298 | biostudies-literature
| S-EPMC7295068 | biostudies-literature
| S-EPMC6895962 | biostudies-literature